Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-09

Clinical Trial Update: Duloxetine for Perimenopausal Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating duloxetine for perimenopausal depression in Major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cymbalta (duloxetine)
  • Duloxetine (DULOXETINE)

Snippet

Sponsor: University of Arizona | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED